UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Annual Report to the Nation on the Status of Cancer, 1975―2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)―Associated Cancers and HPV Vaccination Coverage Levels

JNCI : Journal of the National Cancer Institute, 2013-02, Vol.105 (3), p.175-201

2013

Volltextzugriff (PDF)

Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases

The American journal of surgical pathology, 2022-06, Vol.46 (6), p.765-773

2022

Volltextzugriff (PDF)

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Volltextzugriff (PDF)

Will humor increase the effectiveness of human papillomavirus (HPV) advertising? exploring the role of humor, STD information, and knowledge

Journal of marketing communications, 2023-07, Vol.29 (5), p.491-509

2023

Volltextzugriff (PDF)

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.525

2015

Volltextzugriff (PDF)

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

BMC women's health, 2021-10, Vol.21 (1), p.354-6, Article 354

2021

Volltextzugriff (PDF)

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.713-725

2013

Volltextzugriff (PDF)

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma

Oral oncology, 2014-12, Vol.50 (12), p.1149-1156

2014

Volltextzugriff (PDF)

Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization

Sexually transmitted diseases, 2006-04, Vol.33 (4), p.259-264

2006

Volltextzugriff (PDF)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Infectious agents and cancer, 2023-05, Vol.18 (1), p.29-29, Article 29

2023

Volltextzugriff (PDF)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

PloS one, 2017-06, Vol.12 (6), p.e0177773-e0177773

2017

Volltextzugriff (PDF)

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy

Risk management and healthcare policy, 2017-01, Vol.10, p.29-32

2017

Volltextzugriff (PDF)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

BMC public health, 2012-10, Vol.12 (1), p.872-872, Article 872

2012

Volltextzugriff (PDF)

Knowledge of Greek adolescents on human papilloma virus (HPV) and vaccination: A national epidemiologic study

Medicine (Baltimore), 2017-01, Vol.96 (1), p.e5287-e5287

2017

Volltextzugriff (PDF)

Potential cost‐effectiveness of the nonavalent human papillomavirus (HPV) vaccine

International journal of cancer, 2014-05, Vol.134 (9), p.2264-2268

2014

Volltextzugriff (PDF)

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Frontiers in immunology, 2020-05, Vol.11, p.1012-1012

2020

Volltextzugriff (PDF)

Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV‐positive cancer cells

International journal of cancer, 2013-10, Vol.133 (7), p.1631-1642

2013

Volltextzugriff (PDF)

Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV)

Frontiers in oncology, 2018-01, Vol.8, p.1-1

2018

Volltextzugriff (PDF)

'It's really complicated': How Canadian university women students navigate gendered risk and human papillomavirus (HPV) vaccine decision-making

Health, risk & society, 2016-02, Vol.18 (1-2), p.59-76

Wyndham-West, C. Michelle

2016

Volltextzugriff (PDF)

Medical and public health professionals' perceived facilitators and barriers of human papillomavirus (HPV) vaccination among African American adolescents in Shelby County, Tennessee

BMC health services research, 2023-05, Vol.23 (1), p.469-469, Article 469

2023

Volltextzugriff (PDF)

Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52

Virology journal, 2022-03, Vol.19 (1), p.37-37, Article 37

2022

Volltextzugriff (PDF)

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

PloS one, 2013-07, Vol.8 (7), p.e68329-e68329

2013

Volltextzugriff (PDF)

Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7

Clinical and experimental immunology, 2000-08, Vol.121 (2), p.216-225

2000

Volltextzugriff (PDF)

Instagrammers' attitude towards Human Papillomavirus (HPV) vaccine: A review

Journal of human behavior in the social environment, 2022-02, Vol.32 (2), p.274-282

2022

Volltextzugriff (PDF)

Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries : stakeholders’ perspectives

SAMJ: South African Medical Journal, 2020-06, Vol.110 (6), p.525-531

2020

Volltextzugriff (PDF)

1 – 25 von 21.415

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieHuman Vaccines & Immunotherapeutics

SpracheFranzösisch

SprachePortugiesisch

ThemaMiddle Aged

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20.052)
Mit Volltextzugriff
(18.923)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(17.576)
Life Sciences & Biomedicine
(15.313)
Human Papillomavirus
(9.415)
Humans
(8.819)
Cervical Cancer
(6.208)
Female
(5.116)
Cancer
(4.821)
Oncology
(3.961)
Health Aspects
(3.624)
Tumors
(3.530)
Infections
(3.303)
Proteins
(3.090)
Vaccines
(2.941)
Papillomavirus Infections
(2.792)
Risk Factors
(2.749)
Review
(2.704)
Womens Health
(2.250)
Care And Treatment
(2.193)
Cervix
(2.114)
Science & Technology - Other Topics
(2.059)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(20.674)
EZB Electronic Journals Library
(17.991)
MEDLINE
(9.347)
Journals@Ovid Full Text
(4.721)
Springer Journals
(3.308)
Taylor & Francis Journals
(1.531)
Taylor & Francis Journals Complete
(1.053)
Taylor & Francis
(1.035)
Wiley Online Library
(962)
NUS Single-Journal Subscriptions
(958)
Nexis Uni
(852)
North East Research Libraries Nature Academic Titles
(740)
Elsevier ScienceDirect Journals Complete
(693)
Wiley Online Library
(569)
Applied Social Sciences Index & Abstracts (ASSIA)
(481)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(378)
JSTOR
(366)
Psychology and Behavioral Sciences Collection
(223)
SAGE Archive
(213)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(1.570)
International Journal Of Molecular Sciences
(677)
Vaccines
(598)
Viruses
(468)
Scientific Reports
(441)
Infectious Agents And Cancer
(415)
Oncology Letters
(394)
Cancers
(386)
Bmc Cancer
(324)
Bmc Public Health
(273)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Annual Report to the Nation on the Status of Cancer, 1975―2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)―Associated Cancers and HPV Vaccination Coverage Levels

Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Will humor increase the effectiveness of human papillomavirus (HPV) advertising? exploring the role of humor, STD information, and knowledge

Human papillomavirus (HPV) genome status & cervical cancer outcome--A retrospective study

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma

Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

Knowledge of Greek adolescents on human papilloma virus (HPV) and vaccination: A national epidemiologic study

Potential cost‐effectiveness of the nonavalent human papillomavirus (HPV) vaccine

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV‐positive cancer cells

Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV)

'It's really complicated': How Canadian university women students navigate gendered risk and human papillomavirus (HPV) vaccine decision-making

Medical and public health professionals' perceived facilitators and barriers of human papillomavirus (HPV) vaccination among African American adolescents in Shelby County, Tennessee

Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

Immunotherapy of a human papillomavirus (HPV) type 16 E7‐expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette–Guérin (BCG) hsp65 and HPV16 E7

Instagrammers' attitude towards Human Papillomavirus (HPV) vaccine: A review

Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries : stakeholders’ perspectives

Aktive Filter

Suchergebnisse filtern